• The full-service CRO

    The CRO of choice
    by the leading Investigators

    and Sites

    Serving clients ranging
    from Big Pharma

    to Start-ups

    Combining Global Coverage with true Local Expertise

    In the United States, Europe, Russia and Asia, since 2001

    Continue to the website
    Download brochure

GCT Ukraine is moving to a larger facility

Global Clinical Trials first established its operations and a physical office in Ukraine in 2006. Among other projects, we are presently in the active start-up phase and opening 25 sites for a large global study in non-small lung cancer patients.

It is our pleasure to announce that we are moving to a new location to create an appropriate environment for our growing operations and headcount in the country.

January 7, 2021

The Holiday Season across the globe. It’s time to take the stock of our achievements!

As the winter holidays are celebrated all over the World and the New Year is just around the corner, our global team wants to take a moment to say thank you for your support and partnership.

Have a look at where 2020 took us!

December 24, 2020

New Scientific Project in Russia

GCT has been awarded a new multinational scientific project in patients diagnosed with Schizophrenia and other related psychiatric disorders.

GCT will manage the whole scope of services for the project including the local biosamples logistics and regulatory support.

December 10, 2020

Why CNS Clinical Trials are More Successful in Eastern Europe

With more than 19 years of experience in conducting CNS trials, we are now seeing that studies in Eastern Europe are becoming more and more popular among sponsors worldwide.

Here are the reasons why... (continue reading)

December 9, 2020

GCT to Perform Booster Visits in Russia

The Sponsor is running an international phase III trial in Crohn’s disease. Study recruitment is challenged by initial low incidence of the disease, combined with a big number of competing trials, as well as COVID-19 impact. As an escalation strategy and to reengage sites that are behind on the enrollment, the Sponsor decided to perform booster visits, including on-site visits by GCT team in Russia.

November 30, 2020

Relapsed or Refractory Lymphoma Trial in Russia

Global Clinical Trials is initiating a Phase I clinical study in Relapsed or Refractory Lymphoma for a US biotechnology company, OncoTartis, Inc.

GCT will be responsible for the local study management throughout all stages of the trial, including start-up activities, regulatory submission to Ministry of Health and Local Ethics Committees, project and site management, clinical monitoring, and the full cycle of the complex study logistics.

November 12, 2020

Meet our clients

All trademarks, brand names and logotypes are intellectual property of their respective owners.

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2021 Global Clinical Trials, LLC

All rights reserved.